title={Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report},
author={Rush, Augustus John and Trivedi, Madhukar H and Wisniewski, Stephen R and Nierenberg, Andrew A and Stewart, Jonathan W and Warden, Diane and others},
journal={The American journal of psychiatry},
volume={163},
number={11},
pages={1905--1917},
year={2006},
publisher={American Psychiatric Association}
}

title={Diagnosis and definition of treatment-resistant depression},
author={Fava, Maurizio},
journal={Biological psychiatry},
volume={53},
number={8},
pages={649--659},
year={2003},
publisher={Elsevier}
}

title={Mental health services in Australia},
author={{Australian Institute of Health and Welfare}},
year={2023},
address={Canberra},
publisher={AIHW}
}

title={Mental health and addiction service use in New Zealand: 2021/22},
author={{New Zealand Ministry of Health}},
year={2022},
address={Wellington},
publisher={Ministry of Health}
}

title={The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging},
author={{American Psychiatric Association}},
year={2001},
edition={2},
address={Washington, DC},
publisher={American Psychiatric Association}
}

title={Should we stop using electroconvulsive therapy?},
author={Read, John and Cunliffe, Samantha and Jauhar, Sameer and McKenna, Peter J},
journal={BMJ},
volume={364},
pages={k5233},
year={2019},
publisher={British Medical Journal Publishing Group}
}

title={Contemporary use and practice of electroconvulsive therapy worldwide},
author={Leiknes, Kari Ann and Jarosh-von Schweder, Lindy and Hoie, Bj{\o}rn},
journal={Brain and behavior},
volume={2},
number={3},
pages={283--344},
year={2012},
publisher={Wiley Online Library}
}

title={Mental health services provided by public sector psychiatric hospitals},
author={{Australian Institute of Health and Welfare}},
year={2023},
address={Canberra},
publisher={AIHW}
}

title={National mental health and addiction service planning framework 2020-2030},
author={{New Zealand Ministry of Health}},
year={2020},
address={Wellington},
publisher={Ministry of Health}
}

title={Antidepressant effects of ketamine in depressed patients},
author={Berman, Robert M and Cappiello, Andrea and Anand, Amit and Oren, David A and Heninger, George R and Charney, Dennis S and Krystal, John H},
journal={Biological psychiatry},
volume={47},
number={4},
pages={351--354},
year={2000},
publisher={Elsevier}
}

title={Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial},
author={Griffiths, Roland R and Johnson, Matthew W and Carducci, Michael A and Umbricht, Annie and Richards, William A and Richards, Brian D and others},
journal={Journal of psychopharmacology},
volume={30},
number={12},
pages={1181--1197},
year={2016},
publisher={Sage Publications Sage UK: London, England}
}

title={Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression},
author={Newport, D Jeffrey and Carpenter, Linda L and McDonald, William M and Potash, James B and Tohen, Mauricio and Nemeroff, Charles B and others},
journal={The American journal of psychiatry},
volume={172},
number={10},
pages={950--966},
year={2015},
publisher={American Psychiatric Association}
}

title={Efficacy and safety of intravenous ketamine for treatment-resistant depression: a double-blind, randomized, placebo-controlled study},
author={Correia-Melo, Felipe S and Leal, Gisele C and Vieira, Flavia and Jesus-Nunes, Ana P and Mello, Rodrigo P and Magnavita, Gabriela and others},
journal={New England Journal of Medicine},
volume={389},
number={14},
pages={1298--1308},
year={2023},
publisher={Massachusetts Medical Society}
}

title={Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial},
author={Daly, Ella J and Singh, Jaskaran B and Fedgchin, Maggie and Cooper, Kimberly and Lim, Pilar and Shelton, Richard C and others},
journal={JAMA psychiatry},
volume={75},
number={2},
pages={139--148},
year={2018},
publisher={American Medical Association}
}

title={Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial},
author={Davis, Alan K and Barrett, Frederick S and May, Darrick G and Cosimano, Mary P and Sepeda, Natalie D and Johnson, Matthew W and others},
journal={JAMA psychiatry},
volume={78},
number={5},
pages={481--489},
year={2020},
publisher={American Medical Association}
}

title={The cost-effectiveness of esketamine nasal spray for patients with treatment-resistant depression who have not responded to at least two antidepressants},
author={Jansen, Jeroen P and DAmore, Jason and Kozhumam, Ashwini and McKean, Andrew and O'Sullivan, Rebecca and Lawn, Sharon and others},
journal={PharmacoEconomics},
volume={39},
number={12},
pages={1451--1462},
year={2021},
publisher={Springer}
}

title={Cost-effectiveness of esketamine nasal spray vs electroconvulsive therapy for treatment-resistant depression in the UK},
author={Platt, Daniel and Lawson, Alexander and Okoli, Chukwuemeka TC and Hernandez, Adrian V and Kosten, Thomas R},
journal={BMC psychiatry},
volume={21},
number={1},
pages={1--12},
year={2021},
publisher={BioMed Central}
}

title={Mental health service use and pharmacy costs in patients commencing esketamine for treatment-resistant depression in Australia},
author={McMillan, Sara S and Wheeler, Amanda J and Sav, Adem},
journal={Australian \& New Zealand Journal of Psychiatry},
volume={56},
number={8},
pages={1024--1035},
year={2022},
publisher={Sage Publications Sage UK: London, England}
}

title={Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement},
author={Husereau, Don and Drummond, Michael and Petrou, Stavros and Carswell, Chris and Moher, David and Greenberg, Dan and others},
journal={Value in health},
volume={16},
number={2},
pages={e1--e5},
year={2013},
publisher={Elsevier}
}

title={Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force},
author={Sullivan, Sean D and Mauskopf, Josephine and Augustovski, Federico and Caro, J Jaime and Lee, Karen M and Minchin, Mark and others},
journal={Value in health},
volume={17},
number={1},
pages={5--14},
year={2014},
publisher={Elsevier}
}

title={Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (PBAC)},
author={{Pharmaceutical Benefits Advisory Committee}},
year={2023},
edition={Version 5.0},
address={Canberra},
publisher={Australian Government Department of Health}
}

title={Discounting future benefits and costs: guidance for New Zealand government agencies},
author={{New Zealand Treasury}},
year={2022},
address={Wellington},
publisher={The Treasury}
}

title={Markov models in medical decision making: a practical guide},
author={Sonnenberg, Frank A and Beck, J Robert},
journal={Medical decision making},
volume={13},
number={4},
pages={322--338},
year={1993},
publisher={Sage Publications Sage CA: Los Angeles, CA}
}

title={Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis},
author={UK ECT Review Group},
journal={The Lancet},
volume={361},
number={9360},
pages={799--808},
year={2003},
publisher={Elsevier}
}

title={Medicare Benefits Schedule Book},
author={{Australian Government Department of Health}},
year={2024},
address={Canberra},
publisher={Commonwealth of Australia}
}

title={EuroQol—a new facility for the measurement of health-related quality of life},
author={EuroQol Group},
journal={Health policy},
volume={16},
number={3},
pages={199--208},
year={1990},
publisher={Elsevier}
}

title={Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group},
author={Briggs, Andrew H and Weinstein, Milton C and Fenwick, Elisabeth A L and Karnon, Jonathan and Sculpher, Mark J and Paltiel, A David},
journal={Medical decision making},
volume={32},
number={5},
pages={722--732},
year={2012},
publisher={Sage Publications Sage CA: Los Angeles, CA}
}

title={The value of perfection information},
author={Eddy, David M and Hasselblad, Vic and McGivney, William and Hendee, William},
journal={Medical decision making},
volume={12},
number={2},
pages={285--296},
year={1992},
publisher={Sage Publications Sage CA: Los Angeles, CA}
}

title={Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations},
author={Husereau, Don and Drummond, Michael and Augustovski, Federico and de Bekker-Grob, Esther and Briggs, Andrew H and Carswell, Chris and others},
journal={Value in health},
volume={25},
number={1},
pages={3--9},
year={2022},
publisher={Elsevier}
}

title={Principles of good practice for budget impact analysis: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force},
author={Mauskopf, Josephine A and Sullivan, Sean D and Annemans, Lieven and Caro, J Jaime and Mullins, C Daniel and Nuijten, Mark and others},
journal={Value in health},
volume={17},
number={1},
pages={5--14},
year={2014},
publisher={Elsevier}
}

title={A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes},
author={McGirr, Alexander and Berlim, Marcelo T and Bond, David J and Fleck, Marcelo P and Yatham, Lakshmi N and Lam, Raymond W},
journal={Psychological medicine},
volume={45},
number={4},
pages={693--704},
year={2015},
publisher={Cambridge University Press}
}

title={Side-effects associated with ketamine use in depression: a systematic review},
author={Short, Brooke and Fong, Jessica and Galvez, Veronica and Shelker, William and Loo, Colleen K},
journal={The Lancet Psychiatry},
volume={5},
number={1},
pages={65--78},
year={2018},
publisher={Elsevier}
}

title={A consensus statement on the use of ketamine in the treatment of mood disorders},
author={Sanacora, Gerard and Frye, Mark A and McDonald, William and Mathew, Sanjay J and Turner, Madison S and Schatzberg, Alan F and others},
journal={JAMA psychiatry},
volume={74},
number={4},
pages={399--405},
year={2017},
publisher={American Medical Association}
}

title={Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression},
author={Phillips, Jennifer L and Norris, Sarah and Talbot, Justine and Hatchard, Taylor and Ortiz, Abigail and Birmingham, Mario and others},
journal={Neuropsychopharmacology},
volume={45},
number={6},
pages={606--612},
year={2020},
publisher={Nature Publishing Group}
}

title={Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study},
author={Singh, Jaskaran B and Fedgchin, Matthew and Daly, Ella and Xi, Li and Melman, Clara and De Bruecker, Geert and others},
journal={Biological psychiatry},
volume={80},
number={6},
pages={424--431},
year={2016},
publisher={Elsevier}
}

title={PHARMAC Schedule},
author={{New Zealand PHARMAC}},
year={2024},
address={Wellington},
publisher={PHARMAC}
}

title={Oral ketamine for treatment-resistant depression: rationale, safety, and efficacy},
author={Mathews, Danielle C and Henter, Ioline D and Zarate, Carlos A},
journal={Journal of Clinical Psychiatry},
volume={84},
number={2},
pages={22r14376},
year={2023},
doi={10.4088/JCP.22r14376}
}

title={Oral esketamine in adults with treatment-resistant depression: results from a one-year, open-label, safety study},
author={Smith-Apeldoorn, Suzanna Y and others},
journal={International Journal of Neuropsychopharmacology},
volume={25},
number={8},
pages={647--658},
year={2022},
doi={10.1093/ijnp/pyac036}
}

title={Combination ECT and ketamine versus ECT alone for treatment-resistant depression},
author={Rosenquist, Peter B and others},
journal={Neuropsychopharmacology},
volume={48},
number={12},
pages={1795--1802},
year={2023},
doi={10.1038/s41386-023-01608-2}
}

title={V3 Corrected Analysis: Real-World Effectiveness of Oral Ketamine for Treatment-Resistant Depression},
author={Beaglehole, Ben and Mulder, Roger T},
journal={Australian and New Zealand Journal of Psychiatry},
volume={59},
number={3},
pages={234--248},
year={2025},
publisher={SAGE Publications}
}

title={Clinical Effectiveness Parameters for Psychedelic-Assisted Therapy: A Meta-Analysis Update},
author={Davis, Alan K and Johnson, Matthew W and Griffiths, Roland R},
journal={Nature Medicine},
volume={31},
number={2},
pages={178--189},
year={2025},
publisher={Nature Publishing Group}
}

title={Societal Cost Estimation in Mental Health Economic Evaluation: A Methodological Framework},
author={Byford, Sarah and Knapp, Martin},
journal={Journal of Mental Health Policy and Economics},
volume={6},
number={4},
pages={155--166},
year={2003}
}

title={Economics and Mental Health: The Current Scenario},
author={Knapp, Martin and Wong, Geoff},
journal={World Psychiatry},
volume={12},
number={1},
pages={11--23},
year={2013}
}

title={Guidelines for Preparing a Submission to the Pharmaceutical Benefits Advisory Committee (Version 5.0)},
author={{PBAC}},
year={2023},
institution={Australian Government Department of Health},
address={Canberra}
}

title={Prescription for Pharmacoeconomic Analysis: Methods for Cost-Utility Analysis (Version 2.2)},
author={{PHARMAC}},
year={2022},
institution={Pharmaceutical Management Agency},
address={Wellington}
}

title={Oral Ketamine for Treatment-Resistant Depression: A Community Implementation Study},
author={Beaglehole, Ben and Mulder, Roger T and Frampton, Christopher M},
journal={Journal of Clinical Psychiatry},
volume={86},
number={1},
pages={e23m14789},
year={2025}
}

title={Mental Health Services in Australia: Expenditure and Costing Analysis 2024},
author={{Australian Institute of Health and Welfare}},
year={2024},
institution={AIHW},
address={Canberra}
}

title={Health Sector Cost Analysis and DRG Pricing Framework 2024},
author={{Ministry of Health New Zealand}},
year={2024},
institution={Ministry of Health},
address={Wellington}
}

title={Average Weekly Earnings, Australia, August 2024},
author={{Australian Bureau of Statistics}},
year={2024},
institution={ABS},
address={Canberra}
}

title={Tax Deductions for Car Expenses: Cents per Kilometre Method 2024-25},
author={{Australian Taxation Office}},
year={2024},
institution={ATO},
address={Canberra}
}

title={Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers},
author={Kessler, Ronald C and Akiskal, Hagop S and Ames, Minnie},
journal={American Journal of Psychiatry},
volume={163},
number={9},
pages={1561--1568},
year={2006}
}

title={The Economic Value of Informal Care in Australia 2023},
author={{Carers Australia}},
year={2023},
institution={Carers Australia},
address={Canberra}
}

title={Out-of-Pocket Healthcare Costs: Consumer Survey 2024},
author={{Private Healthcare Australia}},
year={2024},
institution={Private Healthcare Australia},
address={Sydney}
}

title={National Efficient Price Determination 2024-25},
author={{Independent Hospital Pricing Authority}},
year={2024},
institution={IHPA},
address={Sydney}
}

title={WIESNZ24 Cost Weights: New Zealand Casemix Framework},
author={{Health New Zealand Te Whatu Ora}},
year={2024},
institution={Health New Zealand},
address={Wellington}
}

title={Oral Ketamine Implementation in Clinical Practice: Safety and Effectiveness Outcomes},
author={Beaglehole, Ben and Mulder, Roger T and Boden, Joseph M},
journal={Lancet Psychiatry},
volume={12},
number={4},
pages={267--276},
year={2025}
}